Haiquan Chen

14.4k total citations
236 papers, 7.6k citations indexed

About

Haiquan Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Haiquan Chen has authored 236 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Pulmonary and Respiratory Medicine, 82 papers in Oncology and 41 papers in Molecular Biology. Recurrent topics in Haiquan Chen's work include Lung Cancer Treatments and Mutations (124 papers), Lung Cancer Diagnosis and Treatment (105 papers) and Lung Cancer Research Studies (37 papers). Haiquan Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (124 papers), Lung Cancer Diagnosis and Treatment (105 papers) and Lung Cancer Research Studies (37 papers). Haiquan Chen collaborates with scholars based in China, United States and Denmark. Haiquan Chen's co-authors include Yihua Sun, Yuan Li, Yang Zhang, Lei Shen, Hongbin Ji, Yunjian Pan, Xiaoyang Luo, Hong Hu, Haichuan Hu and Ting Ye and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Haiquan Chen

224 papers receiving 7.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haiquan Chen China	47	4.9k	2.9k	2.0k	1.5k	1.2k	236	7.6k
Glenn Liu United States	46	4.9k 1.0×	2.8k 1.0×	2.5k 1.2×	1.8k 1.2×	2.0k 1.6×	175	8.5k
Arne Warth Germany	53	4.2k 0.9×	3.2k 1.1×	2.5k 1.3×	1.7k 1.1×	856 0.7×	236	8.8k
David Olmos United Kingdom	48	6.3k 1.3×	4.1k 1.4×	3.2k 1.6×	3.2k 2.1×	1.4k 1.2×	233	10.4k
Paul G. Corn United States	42	3.2k 0.7×	2.4k 0.8×	5.1k 2.5×	2.1k 1.4×	532 0.4×	190	8.2k
Yoon‐La Choi South Korea	51	4.0k 0.8×	3.9k 1.3×	2.8k 1.4×	2.0k 1.3×	421 0.3×	288	8.3k
Elai Davicioni United States	46	4.4k 0.9×	1.4k 0.5×	2.7k 1.4×	2.5k 1.7×	642 0.5×	296	7.1k
Robert E. Reiter United States	58	7.6k 1.6×	2.8k 0.9×	3.6k 1.8×	2.0k 1.4×	2.7k 2.2×	234	12.0k
Carsten Stephan Germany	58	4.0k 0.8×	1.8k 0.6×	4.9k 2.4×	3.3k 2.2×	650 0.5×	248	10.1k
Marilyn M. Bui United States	44	1.6k 0.3×	2.0k 0.7×	1.6k 0.8×	1.2k 0.8×	1.3k 1.0×	192	6.1k
Johannes H.A.M. Kaanders Netherlands	50	2.2k 0.5×	1.7k 0.6×	1.9k 0.9×	2.5k 1.6×	2.3k 1.8×	177	7.4k

Countries citing papers authored by Haiquan Chen

Since Specialization

Citations

This map shows the geographic impact of Haiquan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiquan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiquan Chen more than expected).

Fields of papers citing papers by Haiquan Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiquan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiquan Chen. The network helps show where Haiquan Chen may publish in the future.

Co-authorship network of co-authors of Haiquan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Haiquan Chen. A scholar is included among the top collaborators of Haiquan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiquan Chen. Haiquan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yang, et al.. (2024). The Overlooked Cornerstone in Precise Medicine: Personalized Postoperative Surveillance Plan for NSCLC. JTO Clinical and Research Reports. 5(8). 100701–100701. 1 indexed citations

Li, Tong, Yang Zhang, Fangqiu Fu, & Haiquan Chen. (2024). The evolution of the treatment of non–small cell lung cancer: A shift in surgical paradigm to a more individualized approach. Journal of Thoracic and Cardiovascular Surgery. 169(3). 737–744.e2. 4 indexed citations

Li, Di, Chaoqiang Deng, Fangqiu Fu, et al.. (2023). Impact of Prior Cancer History on Outcomes of Resected Lung Cancer. Annals of Surgical Oncology. 30(3). 1534–1540. 1 indexed citations

Zhao, Yue, Jiaqiang Ma, Han Han, et al.. (2023). Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma. Cancer Research. 83(16). 2690–2703. 20 indexed citations

Ma, Zelin, Zezhou Wang, Yuan Li, Yang Zhang, & Haiquan Chen. (2022). Detection and treatment of lung adenocarcinoma at pre-/minimally invasive stage: is it lead-time bias?. Journal of Cancer Research and Clinical Oncology. 148(10). 2717–2722. 4 indexed citations

Bai, Jinsong, Chaoqiang Deng, Fangqiu Fu, et al.. (2022). Pregnancy may have little influence on ground-glass opacities suspected for lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 149(4). 1383–1389. 1 indexed citations

Fu, Fangqiu, Yang Zhang, Zhendong Gao, et al.. (2021). Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 147(3). 739–747. 11 indexed citations

Gao, Zhendong, Han Han, Yue Zhao, et al.. (2021). A tumor microenvironment-related mRNA–ncRNA signature for prediction early relapse and chemotherapeutic sensitivity in early-stage lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 147(11). 3195–3209. 3 indexed citations

Zhao, Yue, Yunjian Pan, Chao Cheng, et al.. (2020). EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis. Journal of Cancer Research and Clinical Oncology. 146(7). 1781–1789. 14 indexed citations

10.

Zhang, Yang, Chaoqiang Deng, Xiao Ma, et al.. (2020). Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy. Journal of Cancer Research and Clinical Oncology. 146(9). 2411–2417. 6 indexed citations

11.

Yang, Haiyuan, Ding Ma, Yihua Sun, et al.. (2019). Integration of whole‐genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple‐negative breast cancer. International Journal of Cancer. 145(10). 2850–2860. 15 indexed citations

12.

Li, Jing, Wenjie You, Difan Zheng, et al.. (2018). A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component. Journal of Cancer Research and Clinical Oncology. 144(4). 725–734. 18 indexed citations

13.

Zheng, Shanbo, Xiaoyang Luo, Chuanpeng Dong, et al.. (2018). A B7‐CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma. International Journal of Cancer. 143(10). 2592–2601. 21 indexed citations

14.

Wang, Yiyang, Difan Zheng, Jiajie Zheng, et al.. (2018). Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy. Journal of Cancer Research and Clinical Oncology. 144(6). 1015–1023. 26 indexed citations

15.

Huang, Hsin‐Yi, Wenjing Zhang, Yijun Gao, et al.. (2017). YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation. Cancer Research. 77(21). 5769–5781. 68 indexed citations

16.

Wang, Yiyang, Rui Wang, Difan Zheng, et al.. (2017). The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation. Journal of Cancer Research and Clinical Oncology. 143(10). 2095–2104. 13 indexed citations

17.

Zhang, Yiliang, Yuan Ma, Yuan Li, et al.. (2017). Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?. Journal of Cancer Research and Clinical Oncology. 144(1). 165–171. 6 indexed citations

18.

Zhang, Xu‐Chao, Li Zhang, Changli Wang, et al.. (2013). [Consensus on dignosis for ALK positive non-small cell lung cancer in China, the 2013 version].. PubMed. 42(6). 402–6. 22 indexed citations

19.

Wang, Rui, Yunjian Pan, Chenguang Li, et al.. (2012). The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers. Clinical Cancer Research. 18(17). 4725–4732. 75 indexed citations

20.

Gao, Yijun, Qian Xiao, Li Li, et al.. (2010). LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proceedings of the National Academy of Sciences. 107(44). 18892–18897. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact